MARKET

REVBW

REVBW

Rvltn Bioscnc
NASDAQ
0.0120
-0.0001
-0.83%
Opening 12:23 05/29 EDT
OPEN
0.0121
PREV CLOSE
0.0121
HIGH
0.0121
LOW
0.0120
VOLUME
1.23K
TURNOVER
--
52 WEEK HIGH
0.0398
52 WEEK LOW
0.0050
MARKET CAP
--
P/E (TTM)
-0.0003
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVB last week (0518-0522)?
Weekly Report · 4d ago
Weekly Report: what happened at REVB last week (0511-0515)?
Weekly Report · 05/18 10:30
Revelation Biosciences reports FY25 EPS ($14.35) vs ($1,052.16) last year
TipRanks · 05/11 13:48
Weekly Report: what happened at REVB last week (0504-0508)?
Weekly Report · 05/11 10:27
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Enovis (ENOV) and Revelation Biosciences (REVB)
TipRanks · 05/08 17:31
Watching Revelation Biosciences; Zacks Small-Cap Research Gives Stock $22.50 Price Valuation
Benzinga · 05/08 16:05
Revelation Biosciences GAAP EPS of -$2.71
Seeking Alpha · 05/08 10:55
Revelation Biosciences Q1 net loss widens as expenses rise
Reuters · 05/07 20:50
More
About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVBW stock methods without spending real money on the virtual paper trading platform.